BiotechTube
Home/Aurum Biosciences/Dr David Brennan
DD

Dr David Brennan

Chief Executive Officer

Aurum Biosciences

Therapeutic Areas

NeurologyCardiologyOncologyRadiology

Aurum Biosciences Pipeline

DrugIndicationPhase
ABL-101Acute Ischaemic Stroke (AIS)Phase 2 Planned